what are the different glp 1 drugs Rise of GLP-1 Medications – Magnet The GLP-1 revolution: What UAB

19 This research culminated in the development of dapagliflozin, canagliflozin, and empagliflozin, which were approved by the FDA between 2013 and 2014 for the treatment of T2D

Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats

The average monthly cost for brand-name Saxenda is around $1,800

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial- NoDerivatives 4.0 International licence (CC BY-NC-ND)

Both offer access to GLP-1 therapy, but they package clinical support and behavior change tools differently, which can meaningfully change the value you get for your money